Clinical Research

Understanding Metabolic Effects of GLP-1 Receptor Agonists Beyond Appetite Suppression Recent clinical investigations suggest that GLP-1 receptor agonists, such as semaglutide and tirzepatide, may influence weight loss through mechanisms that …

Gene Therapy for Friedreich Ataxia Cardiomyopathy Shows Promise in Early Trial A phase 1/2 clinical trial evaluating an intravenous adeno-associated viral gene therapy for Friedreich ataxia (FA) cardiomyopathy found the …

FDA Expands Pneumococcal Vaccine Indication for Children and Teens at High Risk The U.S. Food and Drug Administration (FDA) has approved an expanded indication for Merck’s CAPVAXIVE (21-valent pneumococcal conjugate …

Strikes on Qatar’s Helium Facilities Threaten MRI Operations as Global Supply Chain Disruptions Escalate Strikes on Qatar’s liquefied natural gas facilities, linked to the U.S.-Israel military campaign against Iran, have …

Low-Dose Naltrexone Fails to Improve Fibromyalgia Outcomes in Clinical Trial A recent 12-month, randomized, double-blind, placebo-controlled trial has found that low-dose naltrexone (LDN) does not outperform a placebo in reducing …

Understanding Atrial Fibrillation: Risks, Diagnosis and Modern Treatment Options Atrial fibrillation (AFib) is the most common form of cardiac arrhythmia, characterized by an irregular and often rapid heart rate. As …

Common Lyme Disease Tests Miss Majority of Early Cases, New Research Finds Early detection is critical for treating Lyme disease effectively, yet the very tools doctors rely on may be …

Tirzepatide Shows Promise for Obese Patients Undergoing TAVR Recent research indicates that tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, may significantly improve outcomes for …

WHO Task Force Aims to Include Pregnant and Breastfeeding Women in Clinical Trials by 2030 Pregnant and breastfeeding women have historically been underrepresented in medical research, leading to significant gaps …